ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,674.80
      -2.20%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.06
      0.01%
      Bitcoin
      57,376.42
      -0.66%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sonoma Pharmaceuticals Inc (SNOA)

      7. Sonoma Pharmaceuticals Inc (SNOA) News

      SNOA

      Sonoma Pharmaceuticals (SNOA)

      Sonoma Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SNOA
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/05/20188:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
      06/05/20187:05AMGlobeNewswire Inc.U.SK, dermatology arm of Brazilian NC Group, and Sonoma Pharmaceuticals Enter into License Agreement for Exclusive Rights to ...NASDAQ:SNOASonoma Pharmaceuticals Inc
      05/31/20187:05AMGlobeNewswire Inc.Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2018 Financial Results and Conference CallNASDAQ:SNOASonoma Pharmaceuticals Inc
      05/08/20187:00AMGlobeNewswire Inc.Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating OfficerNASDAQ:SNOASonoma Pharmaceuticals Inc
      04/17/20187:04AMGlobeNewswire Inc.Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal ProductsNASDAQ:SNOASonoma Pharmaceuticals Inc
      04/05/20187:05AMGlobeNewswire Inc.Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy GelNASDAQ:SNOASonoma Pharmaceuticals Inc
      03/27/20187:05AMGlobeNewswire Inc.Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene SolutionNASDAQ:SNOASonoma Pharmaceuticals Inc
      03/13/20185:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
      03/09/20182:46PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNOASonoma Pharmaceuticals Inc
      03/09/20187:05AMGlobeNewswire Inc.Sonoma Pharmaceuticals to Present at Roth Capital Partners 30th Annual Growth Stock Conference on March 13, 2018NASDAQ:SNOASonoma Pharmaceuticals Inc
      03/06/20187:27PMGlobeNewswire Inc.Sonoma Pharmaceuticals Announces Closing of $5 Million Public Offering of Common StockNASDAQ:SNOASonoma Pharmaceuticals Inc
      03/06/20184:52PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
      03/05/20184:51PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNOASonoma Pharmaceuticals Inc
      03/02/20188:00AMGlobeNewswire Inc.Sonoma Pharmaceuticals Announces Pricing of $5 Million Public Offering of Common StockNASDAQ:SNOASonoma Pharmaceuticals Inc
      03/02/20186:11AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNOASonoma Pharmaceuticals Inc
      02/13/20182:51PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNOASonoma Pharmaceuticals Inc
      02/07/20184:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
      02/07/20184:05PMGlobeNewswire Inc.Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Rev...NASDAQ:SNOASonoma Pharmaceuticals Inc
      01/25/20187:05AMGlobeNewswire Inc.Sonoma Pharmaceuticals Announces Fiscal Third Quarter 2018 Financial Results and Conference CallNASDAQ:SNOASonoma Pharmaceuticals Inc
      01/09/20187:05AMGlobeNewswire Inc.Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn® for Management of Blepharitis...NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/08/20174:21PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/08/20174:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/05/20177:05AMGlobeNewswire Inc.Sonoma Pharmaceuticals Announces Second FDA Approval to Add Antimicrobial Language to Alevicyn™ Gel Products for Management...NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/04/20174:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/01/20174:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/01/20174:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/01/20174:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
      12/01/20174:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
      11/30/20175:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:SNOA

      Your Recent History

      BIT
      F05979
      Vontobel Financial Produ...
      Delayed Upgrade Clock